Compare the strategies for defending against NPEs using inter partes review versus district court litigation when dealing with aggressive patent assertion entities in the biotech sector.
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
Compare the strategies for defending against NPEs using inter partes review versus district court litigation when dealing with aggressive patent assertion entities in the biotech sector.
3 real searches · 1 real-search pass
USPTO inter partes review statutory framework 35 USC 311 315 316 2025 discretionary denial Fintiv biotech patent litigationGoogle ↗
OBSERVEDReason
Federal Circuit IPR estoppel 35 USC 315(e) district court printed publications scope 2024Google ↗
OBSERVEDReason
biotechnology patent litigation IPR challenges written description enablement patent eligibility district court 35 USC 101 112Google ↗
OBSERVEDReason
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
ChatGPT real searches (3)
Classes come from the query-classifier (a local Laya model). 3 of 3 calls are low-confidence (under 50%) — hover a query in the table to see its confidence.
Searches and sources
ChatGPT3 real searches · gpt-6
USPTO inter partes review statutory framework 35 USC 311 315 316 2025 discretionary denial Fintiv biotech patent litigation Google ↗
Federal Circuit IPR estoppel 35 USC 315(e) district court printed publications scope 2024 Google ↗
biotechnology patent litigation IPR challenges written description enablement patent eligibility district court 35 USC 101 112 Google ↗
- Patent Examination Policy - MPEP Staff - 35 USC 112 1st para - Enablement of Chemical/Biotechnical Applications · uspto.gov
- Inter Partes Review · uspto.gov
- Interim Director Discretionary Process · uspto.gov
- Trial Practice Guide · uspto.gov
- uscode.house.gov · uscode.house.gov
- U.S.C. Title 35 · govinfo.gov
- Guidance on USPTO's recission of "Interim Procedure for Discretionary Denials in AIA Post-Grant Proceedings with Parallel District Court Litigation" · uspto.gov
- Federal Circuit resolves district court split on scope of estoppel after patent IPR challenges · reuters.com
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
USPTO inter partes review statutory framework 35 USC 311 315 316 2025 discretionary denial Fintiv biotech patent litigation OBSERVED | Google ↗ AI Mode ↗ | — | Reason | — | — | 1x of 1 | |
Federal Circuit IPR estoppel 35 USC 315(e) district court printed publications scope 2024 OBSERVED | Google ↗ AI Mode ↗ | — | Reason | — | — | 1x of 1 | |
biotechnology patent litigation IPR challenges written description enablement patent eligibility district court 35 USC 101 112 OBSERVED | Google ↗ AI Mode ↗ | — | Reason | — | — | 1x of 1 |